Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DynoChem is a leading process development and scale-up software platform used extensively in the pharmaceutical and chemical industries. Originally developed by Scale-up Systems and acquired by ACD/Labs in 2021, the software enables scientists and engineers to model chemical reactions, crystallizations, and physical processes. It helps in optimizing manufacturing processes, ensuring safety, and accelerating the transition from lab-scale to commercial production. The platform is used by a majority of the world's top pharmaceutical companies to improve process understanding and reduce experimental costs. By providing mechanistic insights, DynoChem supports Quality by Design (QbD) and Chemistry, Manufacturing, and Controls (CMC) workflows. Its capabilities include kinetic modeling, solubility prediction, and mixing simulation, which are critical for efficient drug substance development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DynoChem.